Thirty-four new drugs have been added. "The NIOSH 2016 Hazardous Drug List is an important resource as well as a tool to raise awareness among workers about the hazards some drugs, enabling workers to take the necessary steps to protect themselves from exposure while doing their job," said NIOSH Director Dr. John Howard, M.D., MPH.
"Understanding the role the microbiome plays in antibiotic-resistant infections is necessary to protect the public's health," said CDC Director Dr. Tom Frieden, M.D., MPH. "We think it is key to innovative approaches to combat antibiotic resistance, protect patients, and improve antibiotic use."
"Many of us in health care have witnessed or experienced workplace violence firsthand," said Ann Scott Blouin, RN, Ph.D., FACHE, executive vice president of Customer Relations for the commission. "It is critical that we share key resources with those in the health care community to help them prepare for and address, as well as hopefully prevent, this type of unfortunate situation from taking place."
"Fifteen years ago this month, anthrax was used as a weapon of domestic terrorism in the U.S. and its use remains a threat today," said Dr. Richard Hatchett, acting director of BARDA. "BARDA is sponsoring the development of NuThrax to help better protect our nation from this threat."
Get ready for 2016's biggest U.S. safety show by viewing dozens of the new products exhibitors will be displaying.
Measles is the fifth vaccine-preventable disease to be eliminated from the Americas, following the regional eradication of smallpox in 1971, poliomyelitis in 1994, and rubella and congenital rubella syndrome in 2015.
EU-OSHA will host it during the 19th European Health Forum in Austria Sept. 28-30.
WHO announced that a forum will be held Nov. 1-2 for the candidates to present their visions to WHO Member States and the public and to answer questions from Member States on their candidacy.
The contest will ideally stimulate development of an app to connect those experiencing an overdose with help.
NIOSH has drafted a new universal performance test protocol applicable to both types of CSTDs. The meeting allows agency personnel to give an update of new protocol developments.
The NCI-supported Early Detection Research Network (EDRN) is a consortium of biomedical investigators who share data on cancer biomarkers, with the goal of pooling their research data into a single searchable network and facilitate techniques for early diagnosis of cancer or cancer risk.
"Brain diseases and disorders affect millions of families worldwide, leading to billions of dollars in medical expenses and lost productivity," said NSF Director France Córdova, who will deliver opening remarks at the event. "This event is intended to promote collaboration and cooperation in emerging, large-scale international brain projects to further advance neuroscience research."
Earthquakes, cyclones, and floods have caused health emergencies in the region in recent years, and emerging diseases that include SARS, MERS CoV, pandemic influenza, and Zika virus also have threatened residents in the region.
About 75 million Americans have high blood pressure, and about half of them don't have it under control, raising their risk of stroke and heart attack, CDC Director Dr. Tom Frieden reiterated Sept. 13.
The authors evaluated the time they spent on four activities (direct clinical face time, EHR and desk work, administrative tasks, and other tasks) and self-reported after-hours work. They concluded that the doctors spent 27.0 percent of their total time on direct clinical face time with patients and 49.2 percent of their time on EHR and desk work.
The pre-conference program identifies 10 technical sessions as "hot topics" for this year—and they look very promising.
Thomas E. Perez renewed partnership agreements with Ecuador, Guatemala, Honduras, Peru, and the Phillippines.
The revised guidance recommends all states and U.S. territories screen for the virus.
The agency's $2.6 million award to DiaSorin Group aims to encourage its development of a high-capacity Zika diagnostic laboratory test, and second, $7 million award is going to OraSure Technologies, Inc.
At no cost to uninsured patients, residents needing certain drugs during an emergency can obtain a 30-day supply at any EPAP participating pharmacy.